HEV is a nonenveloped, single-stranded, positive-sense RNA virus from the Hepeviridae family.
| INTRODUC TI ON
HEV is a nonenveloped, single-stranded, positive-sense RNA virus from the Hepeviridae family. 1 First discovered in 1978 as the causative agent of a non-A, non-B hepatitis epidemic, at least eight genotypes of HEV have since been described. Five of the known genotypes can directly infect humans. 2 In most symptomatic patients with no underlying conditions, an HEV infection resembles typical acute viral hepatitis and usually resolves spontaneously. 3 However, in immunocompromised patients, HEV can cause chronic infections that last longer than 3 months. 4, 5 An understanding of the viral mutations that arise in patients with an impaired or weakened immune response may yield insights into fundamental viral mutational patterns and biases, as well as the rate of turnover in dominant viral sequence.
HEV-3 is zoonotic and usually spreads through contact with or the consumption of infected domestic pigs and pig products. The ~7.2 kb HEV-3 genome consists of three open reading frames. ORF1
is over 5 kb long and codes for a nonstructural polyprotein (NSP) with eight putative domains. 3 ORF2 is nearly 2 kb long and codes for the viral capsid protein, and is the region targeted in HEV vaccine development. 6 ORF3 is a small 144 aa protein that functions as an ion channel and is vital for HEV infection in vivo. 3, [7] [8] [9] Using sequential viral sequences from immunocompromised patients, we
seek to understand what viral mutational patterns can be observed in patients with low to nonexistent immune response, both in the presence and absence of ribavirin treatment.
Summary
The hepatitis E virus can cause chronic infections in immuno-suppressed patients, and cases have been on the rise globally. Viral mutations during such infections are difficult to characterize. We deep-sequenced viral populations from 15 immunocom- 
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| Sample collection
Viral RNA was extracted from 200 μL of patient plasma using QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany). The quality of the extracted RNA was determined using the Bioanalyzer (Agilent RNA 6000 Pico kit). The amount of virus present in the sample was determined using TaqMan quantitative RT-PCR assay (Table S1 ). The assay was conducted on the ViiA 7 Real-Time PCR System (Applied Biosystems, Singapore city, Singapore) using the QuantiTect Probe RT-PCR Kit (Qiagen, Singapore city, Singapore). All primers and TaqMan probes were designed based on 114 human and swine HEV3 sequences available on NCBI. The sequences of the probe and primers used to detect HEV RNA were as follows: 
| Library construction and sequencing
Viral genome amplification was performed based on the protocol as described by Aw et al. 10 A total of 19 of the NUH sequences formed a monophyletic sub-clade that indicated at least one endemic local lineage. The two remaining sequences both came from patient KT8 and fell together on a neighbouring branch, close to a handful of Japanese human-derived sequences, which could be an indication that this was a travel-related infection, or came from a source otherwise unrelated to the major local cluster. Interestingly, the KT14 sequence appeared highly similar to PLT5 sequences. These two patients were diagnosed within months of each other, but were from vastly different age groups and underwent different procedures in two separate departments. Their only shared characteristic was their home F I G U R E 1 ML phylogenetic tree of HEV-3 sequences location. KT14 and PLT5 lived within one kilometre of each other in a neighbourhood distant from the hospital, and may have contracted the virus from the same source within their immediate residential area. Another unique case was patient KT7, whose sequences did not cluster on the phylogeny even though they were collected just 3 months apart. It was unclear whether they might have been two separate infections in the same patient.
We compared the BEAST results to an earlier publication of acute HEV viral sequences collected at the Singapore General Hospital (SGH). 22 Three whole genome sequences available from the paper were also included in our tree. Two fell within the major 
| Mutational hotspots within NUH consensus sequences
Comparing the 21 consensus sequences from NUH samples, we observed single nucleotide variants (SNVs) at 24.7% of sites studied (π = 0.06422, 0.06876, Tajima's D = −0.27416). As expected of a closely related population, the site frequency spectrum (SFS) is skewed towards rare variants, with a bump at 9.5% due to variants shared within pairs of patient samples ( Figure S2 ).
Incomplete codons at the edges of the amplicons were removed for coding sequence analysis. Of the remaining 941 SNVs, 106 were triallelic within the 21 NUH sequences, and 10 had all four nucleotides represented. As might be expected, the majority (98%) of these multi-allelic sites were silent variants, occurring on the third base of the respective codons, and did not impact protein sequence.
Comparison of amino acid sequences generated from the consensus nucleotide sequences showed a total of just 88 amino acid (aa) vari- and ORF2:bp5500-6250(aa120-400) (Figure 4 ). These observations did not change when only one sequence per patient was used (to remove signatures from within-patient mutations). 
| Viral mutations within immunocompromised hosts
Viral populations within each patient timepoint varied in complexity. We used the percentage of sites with MAF >0.05 as a representation of population complexity. Viral populations carried variants with MAF >0.05 at 0.4%-15.7% of investigated sites ( Figure S3 ). As observed in consensus sequence differences, polymorphic variants within each population were predominantly silent, with the number of nonsynonymous variants correlated with the total number of polymorphic sites (R 2 = 0.766).
Timepoint sequence comparisons showed that dominant variants could be replaced rapidly during an active infection. All of the treated patients responded well to RBV treatment and none had relapsed at the time of analysis, thus viral resistance to RBV did not develop in this cohort. We compared the number of base changes in the dominant sequences between two sequential time points from five patients ( Table 1 ). Note that sequences from patient KT7 did not cluster on the phylogenetic tree and might have been two separate infections. Results from this patient should be considered separately.
In general, most second timepoints saw an increase in viral population diversity, as well as a decrease in viral load, regardless of RBV treatment (Table S1) 
| D ISCUSS I ON
The definition and classification of HEV-3 subtypes are continually being updated, 23, 24 and new subtypes are proposed as sequences emerge.
Around 10 subtypes have been named so far within the HEV-3 genotype, with G3abcdhij belonging to one group that is thought to be Asian in origin, and G3efg falling into to a second group believed to be European in origin. 25 Increasing efforts in HEV surveillance has revealed a complex picture of the global circulation of HEV-3 subtypes, with no clear regional demarcations. Subtypes are no longer limited to their regions of origin, such as the discovery of both major HEV-3 groups in UK even though only G3efg has been found in indigenous pigs, 26 as well as the discovery of HEV-3f viruses in Bangkok retail pork in supermarkets. 27 All of the National University Hospital (NUH, Singapore) sequences in this study fall within subtype 3a on the phylogenetic tree. Globally, HEV-3a appears to be a well-travelled lineage, with sequences found in farmed pigs in Canada, China, Columbia, France, Indonesia, Japan, South Korea, and Philippines. [28] [29] [30] [31] [32] [33] [34] [35] It was also recently identified in German wild boars 36 and was the causative agent of an autochthonous human infection in Europe. 37 In our analysis of within-patient mutations, we found that while synonymous changes in the dominant sequence occurred throughout the genome at roughly equal rates, amino acid changes were concentrated in specific regions while nearly absent from others. In patients with impaired immunity, any signatures we observe are presumably predominantly due to negative selection in genomic regions vital for viral function and relaxation of selection everywhere else.
Consensus SNV changes

Consensus aa changes
The location of mutational cold spots and hotspots within patients also appear highly similar to those observed in sequences collected across multiple patients. It is also possible that selective pressures in a porcine host prior to human infection may have partly contributed to the signatures observed. However, we lack porcine sequences from the same lineage that would allow us to confirm a zoonotic source or compare regions under selection in a porcine host.
Across NUH patient sequences, two protein regions were highly conserved, similar to a previous analysis of global HEV-3 genotypes. 40 The first region in ORF1 between aa residues 250-450 covers the entire Y domain (aa241-442), a sequence highly similar to the Rubella virus, 3 and critical to HEV infectivity. 41 The second conserved region in ORF2 between aa residues 120-400 cover the entire S domain (aa130-319) and half of the M domain (aa320-456). S and M domains are parts of the essential components required for virus-like particle VLP self-assembly. 42, 43 Unlike the Y and S/M domains, two other regions appeared highly mutable and were likely under relaxed selection. The first region in ORF1 between aa residues 454-687 span nearly the entire papainlike cysteine protease (PCP) domain (aa443-592) as well as half of the HV domain (aa593-711). The PCP region is thought to be vital in RNA replication and ORF1 self-processing, 44 and there is evidence that it may be involved in host innate immunity inhibition. 45 The second highly mutable region spans nearly the entire fragment of ORF3 assayed, between aa residues 69-109. ORF3 is thought to serve multiple functions including the formation of new virions, facilitating virus release from cells, and ion channel activity. 9 HEV-3 is an increasing concern globally, particularly amongst immunocompromised patients. Recent efforts to understand the disease have led to better efforts at sample collection, allowing the study of the virus with genomic tools. We showed evidence of a local HEV-3a lineage that has been persistent and stable in an environment at least over 2011-2016 since sequencing efforts began, and increasing in prevalence over time. Porcine sequences from the same lineage, in addition to pinpointing a viral source for disease control policies, will also allow a better understanding of the viral adaptation involved in the leap to a different host species. Viral sequences from nonimmunocompromised human patients will also be important to understand the full picture of HEV-3 infection.
